For: | Igata Y, Kudo M, Kojima M, Kami S, Aoki K, Satake T, Kobayashi T, Sugimoto M, Kobayashi S, Konishi M, Gotohda N. Conversion surgery after gemcitabine and cisplatin plus durvalumab for advanced intrahepatic cholangiocarcinoma: A case report. World J Clin Cases 2024; 12(34): 6721-6727 [PMID: 39650816 DOI: 10.12998/wjcc.v12.i34.6721] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v12/i34/6721.htm |
Number | Citing Articles |
1 |
Koshiro Fukuda, Akiyoshi Kasuga, Yasuyuki Shigematsu, Kenichiro Kato, Hiromichi Ito, Arisa Ueki, Takeshi Okamoto, Masato Ozaka, Yu Takahashi, Naoki Sasahira. Pathological complete response following addition of durvalumab to gemcitabine and cisplatin therapy for intrahepatic cholangiocarcinoma with Lynch syndrome-associated mismatch repair deficiency. Clinical Journal of Gastroenterology 2025; doi: 10.1007/s12328-025-02122-1
|